Objective: Retention in HIV care, particularly among postpartum women, is a challenge to national antiretroviral therapy programs. Retention estimates may be underestimated because of unreported transfers. We explored mobility and clinic switching among patients considered lost to follow-up (LTFU).
INTRODUCTION
South Africa's government launched a universal testand-treat policy to provide antiretroviral therapy (ART) to all HIV-positive people-regardless of CD4 + cell count-in September 2016. 1 With more people living with HIV than any other country in the world, South Africa already had the largest ART program before this ambitious development. 2 Expanded ART availability has altered dramatically the health and quality of life of people living with HIV/AIDS, with an estimated life expectancy gain of 11.3 years between 2003 and 2011 because of ART 3 and a 77% decrease in HIV transmission among serodiscordant couples. 4 However, the rapid scale-up of the national ART program has put tremendous pressure on the limited resources of a public health sector that is hurrying to meet immense need. The positive impact of life expectancy gains and improved health through expanded ART availability will only be realized if eligible individuals access care, remain in care, and adhere to treatment.
Despite widespread availability of ART, approximately 162,445 people died of AIDS in South Africa in 2015, representing nearly one-third of the country's total deaths. 5 Many of these deaths could have been avoided through earlier engagement and improved retention in HIV care. The problem of patient dropout, or loss to follow-up (LTFU), within the public sector in South Africa has been well documented. 6, 7 A large collaborative analysis of 8 cohorts initiating ART across South Africa found that patient dropout increased with duration on treatment, and by 36 months, 29% were LTFU. 6 However, misclassification of retention outcomes likely clouds our understanding of the true magnitude of LTFU. As with much of sub-Saharan Africa, HIV care in most of South Africa is provided in decentralized clinics; patient data typically are captured first on paper files then later entered electronically in database programs. No unique patient identifier is used. As a result, when patients move between facilities, because of the highly mobile nature of the population or local "clinic shopping," patient data typically are not transferred to the new facility. Clinics are not yet fully equipped to track patient movement from one facility to another, so a LTFU patient may actually be engaged in care elsewhere. Therefore, estimates of LTFU typically represent patient dropout only from the perspective of a single clinic rather than system-wide retention, a serious limitation. Work in Uganda tracking a sample of patients considered lost has shown that retention estimates were underestimated by "silent transfers" (transfers not reported to the sending facility) between clinics and by unreported mortality. [8] [9] [10] [11] [12] However, manually tracing patients is resource intensive, difficult to bring to scale, and usually relies on self-reported retention.
Access to ART for all HIV-positive pregnant women through Option B+, introduced in South Africa in 2015, 13 has helped to reduce mother-to-child transmission of HIV to the point where near-elimination is now believed possible. 14 Despite this astounding achievement, there is mounting evidence that women who initiate ART during pregnancy may be at very high risk of LTFU, [15] [16] [17] [18] with re-engagement in routine HIV care after delivery a particular concern. 19, 20 Suggested reasons for this high LTFU include a lack of perception of need for treatment, 16, 21 increased financial burden, 16, 22 and stigma. [23] [24] [25] [26] In our recent work, we have observed that HIV-positive women reported difficulty in providing a "valid reason" to be seen at a clinic after giving birth; while pregnant, clinic attendance is accepted, but after delivery, clinic attendance and medication adherence are viewed with societal and familial suspicion. 27 In addition, postpartum women in South Africa may be a particularly mobile group, due in part to a tradition of returning to one's rural home after delivery to receive care from family members. 16, 24, 28 We wished to explore how women travel and access care during the peripartum period, which is characterized by frequent mobility.
Although frequent population mobility in South Africa is known to contribute to the spread of HIV 29, 30 and is theorized to minimize the gains of ART as prevention, 31 its impact on both patient care and programmatic estimates of retention in care is poorly understood. Better estimates of retention in HIV care would allow for resources to be targeted where they are most needed. Because South Africa does not have a national HIV database that allows tracking patients across treatment sites, but does have a national provider of laboratory services, we developed a novel method for tracking movement between HIV clinics and used an existing laboratory database to determine the continuity of HIV care and the frequency of clinic switching among postpartum women considered LTFU in South Africa. We then used geographic information system mapping techniques to describe mobility among women seeking continued care.
METHODS

Study Population
To determine the proportion of women who continued HIV care after being considered LTFU, we conducted a retrospective cohort study using data from the Right to 
Patient Tracing
The South African National Health Laboratory Service (NHLS) conducts nearly all laboratory testing within the public sector HIV treatment program throughout the country and keeps a database of all laboratory results within a central data warehouse. While not a formal research database, patient results can be queried. To determine whether women initiating ART at an RTC-supported clinic received care after being LTFU, we manually traced these 300 women in the NHLS database using 2 methods. First, in September 2015, we searched using the query tool of the NHLS TrakCare Lab online website, which is available for clinicians and researchers through secure log-in. Each woman was queried a minimum of 5 times using combinations of full and/or partial name(s), surname, and date of birth (DOB). Second, we searched for all 300 women again in the complete NHLS National HIV Cohort, using a probabilistic Jaro-Winkler matching algorithm for name and surname set to a minimum match probability of 91%, using SAS 9.4 (SAS Institute, Cary, NC), followed by manually matching on exact DOB.
either the origin clinic-where ART was initiated-or a new destination facility. Starting with the date last seen at the origin clinic, we defined continued HIV care as accessing care at a new facility at any time during the follow-up period, as demonstrated by: (1) at least one CD4 or viral load test on record or (2) any record from a new ART clinic, as shown by the facility name on the laboratory report.
Analysis
Patient characteristics were summarized using counts and proportions for categorical variables; medians and interquartile ranges (IQRs) for continuous data. To assess patterns of movement between clinics, decimal degree coordinates were obtained for each facility where a woman received care by NHLS records or by query on Google Maps. Using ArcMap 10.3.1 (Esri, Inc., Redlands, CA), the coordinates were imported to shapefiles with a WGS 1984 coordinate system. We connected origin and destination facilities using ArcMap's XY-to-line tool, and distance between the origin and destination facilities was calculated using an online tool ( 
RESULTS
Patient characteristics of the 300 women who were considered LTFU after initiating ART during pregnancy at 6 HIV clinics in Johannesburg are shown in Table 1 . Median age and CD4 + cell count at ART initiation were 28.6 years (IQR: 24.8-32.7) and 267 cells per microliter (IQR: 197-334), respectively. Nearly one-third were not self-identified South African nationals. The median time between ART initiation and the last clinic visit at the initiation site was about 3 months (104 days, IQR: 28-251). Figure 1 shows the results of tracing women in the NHLS database. We found at least one record-including from the origin clinic-for nearly all women (93.7%). Of these, over one-third (37.6%) showed evidence of continued HIV care. If we consider all 103 women with a subsequent laboratory record as engaged in care, LTFU in the original cohort of 788 pregnant women initiating ART drops from 38.1% (95% CI: 34.7% to 41.5%) to 25.0% (95% CI: 22.1% to 28.1%).
Among the 103 who continued HIV care, the median time out of care was 304.5 days (IQR: 100-582) and median CD4 on re-entry to care was 355.5 cells per microliter (IQR: 204.5-564) (Fig. 1) . Overall, CD4 values from the last origin clinic visit and the first visit at the new facility were nearly unchanged, with a median increase of 50 cells per microliter (IQR: 285 to 126). Viral load results from the new facility were available for 42/103 women (40.8%); of these, 24 (57.1%) were virally suppressed per South African treatment guidelines (,50 copies/mL), 13 11 (26.2%) had viral loads 50-1000 copies per milliliter, and 7 (16.7%) had .1000 copies per milliliter. Figures 2A, B illustrate the movement between the origin and new facilities. Median distance between the origin and new facility was 21.8 km (IQR: 8.9-276.4). Two-thirds (67.0%) of the 103 women who continued HIV care did so in Gauteng Province-the same province as the origin clinicwith a median distance of 9.9 km (range: 0.6-81.6) between facilities ( Fig. 2A) . For the remaining 33% who continued care elsewhere in South Africa, the median distance between facilities was 376 km (276-527) (Fig. 2B) . Women who visited a new facility within Gauteng Province stayed out of care longer (median 373.0 vs. 175.5 days) and their median CD4 values on return were lower (327 vs. 493 cells/mL) than those who sought care elsewhere in South Africa (Fig. 1) . Those who continued care outside of Gauteng Province had a greater CD4 increase (median 79 cells/mL; IQR: 55-170) on re-entering care than those who sought care within Gauteng (median: 25 cells/mL; IQR: 294.5 to 115.5).
Our analysis also found further movement beyond just the first new facility. Overall, 103 (37.6%) women accessed at least one new facility, 18 (6.4%) accessed 2 or more, 6 (2.1%) accessed 3 or more, and 2 (0.7%) accessed 4 distinct facilities after dropping out of care from the origin site. Figure 3A , B display the movement of the 18 women who accessed at least 2 new clinics, showing that movement occurred both within Gauteng Province and to outside provinces.
DISCUSSION
We found substantial evidence of continued HIV care among women considered LTFU after initiating ART during pregnancy, both within the same city and in other provinces within South Africa. If we consider all the 103 women who had records at a new clinic as engaged in care, LTFU in the original cohort drops substantially, from 38.1% to 25.0%, a 13% underestimation of retention in care. It is important to note that laboratory records are a limited proxy for retention, as they do not show the full picture of clinic visits, pharmacy pick-ups, or adherence, but we found evidence to suggest that current continuum of care estimates of retention may be overly pessimistic because of outcome misclassification. In our study, over one-third of women considered LTFU had accessed care at a new site, often referred to a "silent transfer" 11 in retention research. To our knowledge, this is the first study to spatially analyze movement between health care facilities. In doing so, we discovered that most women accessed care at a new facility close to where they initiated ART, whereas another one-third accessed care in a different province. We characterize those who accessed care close to their origin clinic as "clinic shoppers" and we were surprised to find that this group had poorer health outcomes on returning to care than those who accessed care away from Johannesburg. This rather counterintuitive finding may be because women who traveled out of the province were more motivated to remain in care, or that those who returned to care in Gauteng Province had already traveled to a rural home after delivery and returned to care only on resettling in Gauteng. It is also important to note that among a small sample, we found evidence of frequent clinic switching: 2, 3, and 4 new facilities, both within Gauteng Province and outside, after seeming to drop out of the initiation site. Stigma, lack of purposeful disclosure, and fear of accidental disclosure have been identified as substantial barriers to retention in postpartum care, 23, [25] [26] [27] and the desire to seek anonymity may influence the decision to "shop" around to local facilities. Therefore, women in the "clinic shopper" group may have dropped out of care and delayed returning until sickness, then chose to return to a different clinic. Follow-up qualitative research to explore women's mobility around the time of delivery and how it impacts retention in care and choice of facility is needed to better understand these quantitative findings. Our study demonstrated mobility among those who accessed care, but the mobility of women who did not access care is not represented; thus, the mobility within our study populationwhether local, national or international-likely is higher than we found through tracing national laboratory records.
Although we found evidence of continued HIV care, the outlook is still suboptimal. Women dropped out of care quickly after initiating ART-the median time from initiation visit to last clinic visit was just 3 months (104 days, IQR: 28-251)-which highlights the need for enhanced retention counseling given the expansion of ART through the universal test-and-treat policy. Even if we reclassify all 103 women with just one continued visit as engaged in care, 25% LTFU is still unacceptably high. All the women in this cohort initiated ART during pregnancy; dropping out of care puts them at risk of immunosuppression and death, as well as transmission of the virus to the baby. Furthermore, we found that women are suspending care for extended periods of time before re-engaging, with CD4 counts remaining relatively low and viral loads increasing during the time out of care. This was most apparent in the group of "clinic shoppers" seeking alternative clinics in Gauteng Province, whose median time between laboratory tests was over a year (373 days, IQR: 175-790), despite eventually going to a new facility very close (median ,10 km) to where they started. Overall, fewer than half (40.3%) of those who accessed a new facility received a viral load test. Consistent retention in postpartum HIV care remains a substantial challenge in South Africa, both from an individual and a health systems perspective, and one that may be exacerbated by expansion of ART availability through Option B+ and test-and-treat policies.
This study adds to the small body of work within the sub-Saharan African region examining continued care among individuals considered LTFU after ART initiation. 11, [32] [33] [34] Our study manually linked existing data sources to search for all lost patients, rather than physically tracing a sample of lost patients in the community. This method has advantages and disadvantages. One advantage is that we did not rely on patient-reported retention, which may be subject to bias, and when available, laboratory records contain extremely useful clinical data. Also, because clinicians in South Africa have access to NHLS's web query tool, this method of patient tracing could be used to search national laboratory results in real time during patient care. However, even if this were possible, given time and resource constraints, the manual searching of patients is cumbersome, requiring patience and diligence. For example, for a patient with the first name Beverly, we found matching records with 5 spellings: "Beverly," "Beverley," "Bereley," "Bevelly," and "Bervely." In addition to misspellings, we often encountered confusion between first and middle names and DOB transposing errors. Manually searching for lost patients took many hours and is more feasible as a research exercise than as a routine clinical follow-up. Although we used 2 different techniques for matching records, it is possible that we still missed records or misclassified matches, resulting in either overmatching or undermatching. Also, because of differing periods of followup time, some participants had more time to meet the definition of continued in care than others.
An additional limitation is that laboratory records do not contain pregnancy information, so we do not know the timing of delivery and cannot determine the transition from antenatal to postpartum care. However, considering that the median time out care among women who continued care was over 300 days, we can assume that most were no longer pregnant with the index pregnancy. Death records also were unavailable, so ascertainment of death may be incomplete. Furthermore, laboratory records do not tell us why the patient accessed care-whether for a routine visit or otherwise-or the complete timeline of continued care, as a laboratory-based test may not have been completed at each visit. In addition, almost 30% of our cohort self-identified nationality other than South African, but the laboratory database only contained records from within South Africa; thus, we cannot comment on cross-border mobility. For these reasons, we consider this work to be a proof of concept to demonstrate that women are continuing care after LTFU in the absence of a national, linked clinical database.
Our findings highlight the difficulty of producing accurate estimates of retention in care in the context of frequent mobility and clinic switching. This movement affects not only estimates of retention in care for epidemiologic research but also real-world patient care because clinical data from other sites are unavailable in real time. We have demonstrated that patients are moving facilities, but unless a patient requests a formal transfer, their records do not move. As countries like South Africa weigh their future health care reporting systems, results like these emphasize the urgent need for a national database with improved data quality management, linked by a unique identifier to improve health services for a highly mobile population.
